Pacific's Osteopatch enters US trial:
This article was originally published in Clinica
Pacific Biometrics has completed pilot clinical studies of the Osteopatch skin patch, designed for management of osteoporotic disease. The non-invasive system consists of a patented transdermal sweat collection device, assays for bone loss markers in sweat and a proprietary method for laboratory analysis. A US trial in 300 patients will begin soon and will take three to four months to complete, after which the company will make a 510(k) filing. 28 million people in the US are at risk for osteoporosis, a number that the National Osteoporosis Foundation believes will grow to 41 million by 2015.
You may also be interested in...
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.
At the OurCrowd Global Investor Summit, in Jerusalem, Israel, on 13 February, Medtech Insight met with start-up Sweetch, which has developed a personalized digital health coach for wellness and disease management.
Medtech Insight attended the OurCrowd Global Investor Summit in Jerusalem on February 13. At the meeting, Ofer Barnea, CEO of neurosurgery start-up SynCath Neuroscience, explained his company’s device to treat cerebral edema,